Yuichi Sesumi
Sayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 09, 2018
A Case of Resected Superior Sulcus Tumor with Pathological Complete Response after Trimodality Therapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 25, 2018
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 27, 2017
Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 23, 2017
Prognostic impact of pleural lavage cytology in patients with primary lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 26, 2016
Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 19, 2016
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer.
Journal: Molecular cancer therapeutics
Published: June 27, 2016
Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer.
Journal: Cancer science
Published: December 15, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026